Financials data is unavailable for this security.
View more
Year on year American Oncology Network Inc had net income fall from a gain of 0.00 to a loss of 5.54m despite a 11.27% increase in revenues from 1.15bn to 1.28bn. An increase in the cost of goods sold as a percentage of sales from 91.70% to 93.53% was a component in the falling net income despite rising revenues.
| Gross margin | 5.27% |
|---|---|
| Net profit margin | -3.26% |
| Operating margin | -2.90% |
| Return on assets | -13.15% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, American Oncology Network Inc increased its cash reserves by 5.99%, or 1.61m. Cash Flow from Financing totalled 55.27m or 4.32% of revenues. In addition the company used 18.12m for operations while cash used for investing totalled 35.53m.
| Cash flow per share | -2.84 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -2.42 |
|---|---|
| Tangible book value per share | -3.25 |
More ▼
